
News|Articles|November 11, 2025
An Analysis of solid tumor oncology patients’ respiratory vaccination rates in accordance with the 2024 American Society of Clinical Oncology (ASCO) guidelines
Author(s)Sponsored by Pfizer
Key Takeaways
Trending on Managed Healthcare Executive
1
A Milestone in Vitiligo: Clinical Efficacy and Long-Term Repigmentation Trends
2
Langlara, third interchangeable biosimilar to Lantus, approved by FDA
3
Cancer patients taking GLP-1s less likely to develop advanced disease | ASCO 2026
4
FDA approves first treatment for chronic hepatitis D virus
5

























